Abstract: The present invention relates to production of therapeutic potential WJ-MSCs for clinical purposes. The WJ-MSCs cultured in optimal culture conditions for production of clinical grade WJ-MSCs wherein 4 different culture media which are Media A, Media B, Media C and Media D used to produce 4 types of WJ-MSCs with different therapeutic potential. The WJ-MSCs harvested from Media A has therapeutic potential related to immune, wound healing and cell migration and the WJ-MSCs harvested from Media B has therapeutic potential related to localization, cell proliferation and cell migration. Meanwhile, the WJ-MSCs harvested from Media C has therapeutic potential related to organ development and osteogenesis and the WJ-MSCs harvested from Media D has therapeutic potential related to tissue development, cell signaling and localization.
Type:
Application
Filed:
June 9, 2023
Publication date:
October 12, 2023
Applicant:
CRYOCORD SDN BHD
Inventors:
Ming Foong CHAI, Zhi Xin LEE, Vijayendran GOVINDASAMY, Soon Keng CHEONG, Khong Lek THEN